Omeros(OMER.US)

Event Tracking

Dec26

Omeros Corporation Receives FDA Approval for YARTEMLEA®

23:36

Nov18

Omeros Corporation's Q3 Earnings Call Highlights Strategic Partnership with Novo Nordisk

00:12

Nov14

Omeros released FY2025 9 Months Earnings on November 13 After-Market EST, actual revenue USD 0, actual EPS USD -1.4768

00:00

Omeros released FY2025 Q3 earnings on November 13 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4665 (forecast USD -0.4475)

00:00

Nov6

Omeros to Release FY2025 Q3 Earnings on November 13 After-Market EST, Forecast EPS USD -0.4475

00:05

Oct15

Novo Nordisk Obtains Exclusive Development and Commercialization Rights for Omeros' ZALTENIBART

12:30

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -30.92 M, EPS -0.4665

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.42 M, EPS -0.4339

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -33.46 M, EPS -0.5763

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change